CEO & Co-Founder
Today's diagnostic model relies on a single annual snapshot: a hospital blood draw, which is precisely why the disease can progress silently between visits. For example, Chronic Kidney Disease (CKD) affects more than 850 million people worldwide, yet 9 out of 10 patients remain unaware of it until the damage is irreversible. This talk explores why weekly, non-invasive, at-home kidney monitoring could close that gap and introduces a next-gen diagnostic platform as a real-world example of how this shift from reactive to proactive healthcare can work in practice. The session will cover: • Why annual check-ups create a dangerous blind spot for silent, progressive conditions like CKD. • A live walkthrough of how a weekly at-home test can build a personal health baseline and flag early drift. • Where this platform is headed next: from CKD monitoring today to longevity and biological-age tracking tomorrow.